Will Cyramza with health insurance benefits broaden options for stomach cancer patients?

Published: 2018-05-04 16:28:00
Updated: 2018-05-04 17:08:00

Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients?

Lilly Korea, on the 2nd, held a press conference to celebrate the Korean health insurance benefits...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.